title: Octreotide and low-fat breast milk in postoperative chylothorax.
abstract: Chylothorax is a rare complication following cavo-pulmonary connection and can lead to significant morbidity in infants and young children. We report here the case of a 3-month-old infant who underwent bilateral cavo-pulmonary connections, and developed severe chylothorax refractory to the usual conservative and surgical treatments. His chylothorax resolved after using a combination of parenteral octreotide (Sandostatin, Novartis Pharmaceuticals, East Hanover, NJ) and low-fat breast milk.
authors.affiliation: Department of Pediatrics, King Abdulaziz Medical City, Al Ahsa, Saudi Arabia. hamdanma@ngha.med.sa
authors.forename: Mohamed A
authors.initials: MA
authors.lastname: Hamdan
authors.forename: Mary Lou
authors.initials: ML
authors.lastname: Gaeta
mesh_terms: D002916:Chylothorax / Q000188:drug therapy* / Q000209:etiology; D018610:Heart Bypass, Right / Q000009:adverse effects*; D006330:Heart Defects, Congenital / Q000601:surgery; D006801:Humans; D007223:Infant; D008297:Male; D008895:Milk, Human; D015282:Octreotide / Q000008:administration & dosage*
chemical_list: D015282:Octreotide